摘要
血青苷是一种大而多功能的糖蛋白,在包括节肢动物和软体动物在内的许多海洋无脊椎动物中具有多种免疫和生物功能。本综述讨论了va。2000~20年间报道的软体动物血青苷的抗病毒活性、免疫刺激和抗癌等药理应用16.重点放在对血蓝苷作为治疗剂的更好的机械理解上。阐明其作用机制对于提高临床疗效和提高疗效至关重要。了解这种复杂糖蛋白的内源性免疫功能。
关键词: 血青苷,软体动物,作用机制,抗病毒活性,免疫治疗,癌症疫苗。
Current Medicinal Chemistry
Title:From Ocean to Bedside: the Therapeutic Potential of Molluscan Hemocyanins
Volume: 25 Issue: 20
关键词: 血青苷,软体动物,作用机制,抗病毒活性,免疫治疗,癌症疫苗。
摘要: Hemocyanins are large and versatile glycoproteins performing various immunological and biological functions in many marine invertebrates including arthropods and molluscs. This review discusses the various pharmacological applications of mollusc hemocyanin such as antiviral activity, immunostimulatory and anticancer properties that have been reported in the literature between the years 2000 and 2016. Emphasis is placed on a better mechanistic understanding of hemocyanin as a therapeutic agent. Elucidation of the mechanism of action is essential to improve the clinical efficacy and for a better understanding of some endogenous immunological functions of this complex glycoprotein.
Export Options
About this article
Cite this article as:
From Ocean to Bedside: the Therapeutic Potential of Molluscan Hemocyanins, Current Medicinal Chemistry 2018; 25 (20) . https://dx.doi.org/10.2174/0929867324666170502124227
DOI https://dx.doi.org/10.2174/0929867324666170502124227 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeted Alpha Therapy with 213Bi
Current Radiopharmaceuticals Intravesical Drug Delivery into the Bladder to Treat Cancers
Current Drug Delivery p53: Fighting Cancer
Current Cancer Drug Targets Effect of Environmental Substances on the Activity of Arylamine N-Acetyltransferases
Current Drug Metabolism Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses
Current Gene Therapy PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Current Pharmaceutical Design Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
Current Medicinal Chemistry Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Current Medicinal Chemistry Tumor Stroma Manipulation By MSC
Current Drug Targets Synthetic Methods for the Preparation of Triazepandiones and Review of their Applications
Current Organic Chemistry Palifermin in theManagement of Mucositis in Hematological Malignancies: Current Evidences and Future Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry Analysis of Capsaicinoids in Hot Sauces Using a Silica Hydride-Based Stationary Phase
Current Chromatography Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews Retinoids as Differentiating Agents in Oncology: A Network of Interactions with Intracellular Pathways as the Basis for Rational Therapeutic Combinations
Current Pharmaceutical Design Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Current Cancer Drug Targets Fluorescence Detection of MMP-9. I. MMP-9 Selectively Cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys Peptide
Current Pharmaceutical Biotechnology New Strategies Against Prostate Cancer – Pt(II)-Based Chemotherapy
Current Medicinal Chemistry Vitamin D and Infectious Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets